← FDA DRUG APPROVALS

FDA ANDA · ANDA089359

HYDRALAZINE HYDROCHLORIDE

Sponsor: TP ANDA HOLDINGS

APPLICATION
ANDA089359
TYPE
ANDA
ORIGINAL APPROVAL
1986-07-25
LATEST ACTION
2000-05-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDRALAZINE HYDROCHLORIDEDiscontinued
HYDRALAZINE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2000-05-16Manufacturing (CMC) · Supplement 11AP
2000-05-16Manufacturing (CMC) · Supplement 12AP
1997-12-05Manufacturing (CMC) · Supplement 10AP
1997-02-24Manufacturing (CMC) · Supplement 9AP
1996-09-16Labeling · Supplement 8AP
1996-03-25Labeling · Supplement 7AP
1995-06-22Manufacturing (CMC) · Supplement 6AP
1994-01-21Manufacturing (CMC) · Supplement 4AP
1994-01-12Manufacturing (CMC) · Supplement 5AP
1989-12-06Labeling · Supplement 3AP
1986-07-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →